Nanovaccines with cell-derived components for cancer immunotherapy

Title
Nanovaccines with cell-derived components for cancer immunotherapy
Authors
Keywords
Nanovaccine, Cell lysates, Whole cell vaccine, Cell-derived nanovesicles, Cell membranes-based nanovaccine, Cancer immunotherapy
Journal
ADVANCED DRUG DELIVERY REVIEWS
Volume 182, Issue -, Pages 114107
Publisher
Elsevier BV
Online
2022-01-05
DOI
10.1016/j.addr.2021.114107

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started